About: Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article by Hiroaki Shima et al published 1 August 2018 in Cancer Immunology, Immunotherapy

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2018 (uk) article scientifique publié en 2018 (fr) im August 2018 veröffentlichter wissenschaftlicher Artikel (de) scholarly article by Hiroaki Shima et al published 1 August 2018 in Cancer Immunology, Immunotherapy (en)
publication date	wds:Q56524291-2C611958-13F5-4075-844F-12B63A9214D0
publication date	2018-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56524291-7736ADB3-6632-423B-B216-12135F9A3A60
language of work or name	English
exact match	wds:Q56524291-9E6321FE-A9ED-4494-91C5-049D57FC5EE3
exact match	https://scigraph.springernature.com/pub.10.1007/s00262-018-2217-x
cites work	wds:Q56524291-1D52F240-9B9E-4BAC-BD78-884330F3B5DC wds:Q56524291-2B139B7F-2689-4365-AC02-E8428BA8F0CF wds:Q56524291-2F113520-2E51-40EE-8A98-C79638A2B081 wds:Q56524291-3A0D05EF-8821-4DF0-8183-4CFAE02C0700 wds:Q56524291-4CF24569-5318-4645-AE9B-2164F424F930 wds:Q56524291-5CF15BA2-685D-4541-B187-AEE743FEC30D wds:Q56524291-6627D88C-5068-42E7-84E9-B83F05F3CAE0 wds:Q56524291-66593A07-A5D1-41B4-AC6A-4C5CC3F7B288 wds:Q56524291-696DDBD7-56A2-4D86-869A-209976C84D56 wds:Q56524291-6A9B770C-2E94-4AED-83BD-2A4BA4B51AD6 wds:Q56524291-6BE89910-F6BF-4456-89A9-2A5E69E9AF5D wds:Q56524291-73BF69FE-22D1-4F7C-B098-F849DD8C7556 wds:Q56524291-795A06BD-1001-48C7-B5EA-B2BBE96EB7EF wds:Q56524291-7E02FDB0-8431-439D-AA28-860AA63310A2 wds:Q56524291-97A4A4BA-251E-43C5-9D9C-1738C957CCC2 wds:Q56524291-B59CDF23-BB2D-4DE9-A9DD-3AFA84A82E52 wds:Q56524291-C7FF2992-A48D-4A90-BEEA-65E3B70FDF06 wds:Q56524291-EE69666A-191E-40AA-A0AE-12987E147550 wds:Q56524291-FAC554AC-6451-4F1C-B70F-D69B0F7D0214
cites work	Cancer immunotherapy: moving beyond current vaccines Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer Adjuvants for peptide-based cancer vaccines CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759] Potential survival benefit of anti-apoptosis protein: survivin-derived peptide vaccine with and without interferon alpha therapy for patients with advanced or recurrent urothelial cancer--results from phase I clinical trials Immune surveillance by the liver Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients Adjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - Trial Watch: Peptide-based anticancer vaccines Specific cytotoxicity of a long-term cultured T-cell clone on human autologous mammary cancer cells. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC.
author name string	wds:Q56524291-A18E1F37-F695-4D75-8F44-BDDAC9574D82 wds:Q56524291-F03023D2-9BA0-47B5-A5F5-2F85BC6227A9
author name string	Masafumi Imamura Kazue Watanabe
rdfs:label	Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine (en) Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine (nl)
skos:prefLabel	Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine (en) Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine (nl)
name	Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine (en) Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine (nl)
author	wds:Q56524291-053A4FE2-C6FE-4B78-89A5-A22D7DDF3042 wds:Q56524291-071C711B-7F15-4276-A2E4-890715A2AAF9 wds:Q56524291-345D61A4-2647-49D2-B13B-DC03CE9AE07A wds:Q56524291-39FBCFEE-B65B-445B-941B-80DAC231E376 wds:Q56524291-3E203EB2-544C-44EB-9606-9012F3B471DB wds:Q56524291-45C04980-1285-4FA8-80F1-774EB438FC10 wds:Q56524291-585680E2-9296-46A3-B154-4F6B8DF2C502 wds:Q56524291-7DB618D2-5BC8-4A80-A122-52208372E3A9 wds:Q56524291-8F915E21-0243-4804-AD53-F62BA8CB6727 wds:Q56524291-92B2D6FF-A40C-4066-8A2F-B00D93BA05DC wds:Q56524291-9A492BC5-6A50-4512-A474-4C8573293DC8 wds:Q56524291-A1C704A6-AF5F-4DAD-ADBA-2EBC7F43B2C1 wds:Q56524291-AA43321D-F534-4807-84ED-D5A7DDD1E487 wds:Q56524291-AE15F260-34DA-484D-A41F-569489D03CB9 wds:Q56524291-CF68C325-781B-4331-A72F-9148AD6FA8B1 wds:Q56524291-D6EB1639-4E28-441F-93D4-62A49E86DD0D
author	Yoshihiko Hirohashi Ichiro Takemasa Noriyuki Satō Tomohide Tsukahara Toshihiko Torigoe Goro Kutomi Akari Takahashi Takayuki Kanaseki Fukino Satomi Tetsuhiro Tsuruma Yuji Iwayama Yasutoshi Kimura Aiko Murai Toru Mizuguchi Hidekazu Kameshima Hiroaki Shima
title	wds:Q56524291-3B393DE8-6BDC-4A57-BA0A-D0AEBB30805D
title	Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine (en)
page(s)	wds:Q56524291-133A14B1-93EB-4943-BB6E-6F4AAC61F003
page(s)	1603-1609
instance of	wds:Q56524291-E377B6AE-9B94-42B7-82C5-66C72404354E
instance of	scholarly article
main subject	wds:Q56524291-02C54EAA-2A07-41B4-81C4-B09376551E10 wds:Q56524291-298143A3-663E-4997-B295-BE4B3799B3FA

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software